Kristi J. Smock, MD

Medical Director: Hemostasis/Thrombosis Laboratory
Professor (Clinical), University of Utah School of Medicine

Specialties

• Hemostasis/thrombosis
• Hematopathology

Education

• Medical Degree—University of Utah School of Medicine
• Residency—Anatomic and Clinical Pathology, University of Utah School of Medicine
• Fellowship—Hematopathology, University of Utah School of Medicine

Certification/Affiliations

• American Board of Pathology (Anatomic and Clinical Pathology, Hematology)

Research Interests

• Broad interests across laboratory hemostasis/thrombosis

Current Roles

• President—North American Specialized Coagulation Laboratory Association (NASCOLA)
• Vice Chair—College of American Pathologists (CAP) Hemostasis and Thrombosis Committee
• Treasurer—Thrombosis and Hemostasis Societies of North America (THSNA)

Awards

• Distinguished Editorial Service, Research and Practice in Thrombosis and Haemostasis (RPTH)
• The Bill Roberts Award for Clinical Excellence in Laboratory Medicine, University of Utah
• Outstanding Teaching Award in Clinical Pathology, University of Utah
• 40 Under Forty Honoree, recognition of achievements and leadership qualities making a significant impact on the fields of pathology and laboratory medicine, American Society for Clinical Pathology (ASCP).

Recent Publications

• Smock KJ. Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease. Int J Lab Hematol. 2023;45 Suppl 2:23-29.
• Smock KJ, Gosselin RC. Laboratory diagnostics for thrombosis and hemostasis testing-part II. Semin Thromb Hemost. 2023;49(6):569-570.
• Smock KJ, Moser KA. Automation of a factor XIII activity assay utilizing a plasma blank measurement. Methods Mol Biol. 2023;2663:693-706.
• Abou-Ismail MY, Kanack AJ, Splinter NP, et al. Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. Blood Adv. 2022;6(18):5327-5329.
• Salazar E, Long TA, Smock KJ, et al. Analysis of College of American Pathologists von Willebrand factor proficiency testing program. Semin Thromb Hemost. 2022;48(6):690-699.
• Smock KJ, Gosselin RC. Laboratory diagnostics for thrombosis and hemostasis testing-part I. Semin Thromb Hemost. 2022;48(6):631-633.
• Kanack A, Bayas A, George G, et al. Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT. Blood. 2022;140(1):73-77.
• Kanack AJ, Singh B, George G, et al. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. Am J Hematol. 2022;97(5):519-526.
• Pikta M, Vasse M, Smock KJ, et al. Establishing reference intervals for von Willebrand factor multimers. J Med Biochem. 2022;41(1):115-121.
• Volod O, Rollins-Raval M, Goodwin AJ, et al. Interlaboratory performance in measurement of dabigatran and rivaroxaban. Arch Pathol Lab Med. 2022;146(2):145-153.
• Mathew Thomas V, Gilreath JA, Newton S, et al. Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. Haemophilia. 2021;27(4):e563-e566.
• Smock KJ, Moser KA. Cryptogenic oozers and bruisers. Hematology Am Soc Hematol Educ Program. 2021;2021(1):85-91.
• Abou-Ismail MY, Moser KA, Smock KJ, et al. Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. Am J Hematol. 2021;96(9):E346-E349.
• Moser KA, Smock KJ. Direct oral anticoagulant (DOAC) interference in hemostasis assays. Hematology Am Soc Hematol Educ Program. 2021;2021(1):129-133.
• Smock KJ. ADAMTS13 testing update: focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies. Int J Lab Hematol. 2021;43 Suppl 1:103-108.
• Carter-Febres M, Smock KJ, Ware AL, et al. Improvement of bleeding manifestations of acquired von Willebrand syndrome after balloon aortic valvuloplasty in a child with aortic stenosis. Prog Pediatr Cardiol. 2021;60:101334.
• Moyer AM, McMillin GA, Long TA, et al. Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing. Arch Pathol Lab Med. 2020;144(9):1057-1066.
• Hayward CPM, George TI, Van Cott EM, et al. Patient advocacy and its importance to laboratory medicine practice. Int J Lab Hematol. 2020;42 Suppl 1:21-22.
• Liederman Z, Van Cott EM, Smock K, et al. Heparin-induced thrombocytopenia: an international assessment of the quality of laboratory testing. J Thromb Haemost. 2019;17(12):2123-2130.
• Van Cott EM, Smock KJ, Lippi G. Innovations in thrombosis and hemostasis: a glimpse toward the future of diagnostic analyzers. Sem Thromb Haemost. 2019;45(3):225-227.
• Smock KJ, Moser KA. What have we learned from coagulation laboratory participation in external quality programs? Int J Lab Hematol. 2019;41(Supp 1):49-55.
• Chandler WL, Brown AF, Chen D, et al. External quality assurance of platelet function assays: results of the College of American Pathologists proficiency testing program. Arch Pathol Lab Med. 2019;143(4):472-482.
• Khan J, Schmidt RL, Spittal MJ, et al. Venous thrombotic risk in transgender women undergoing estrogen therapy: a systematic review and metaanalysis. Clin Chem. 2019;65(1):57-66.